Related Experiment Video
Updated: Aug 5, 2026
06:27
Accelerated Type 1 Diabetes Induction in Mice by Adoptive Transfer of Diabetogenic CD4+ T Cells
Published on: May 6, 2013
Type 1 diabetes in older populations
Anna R Kahkoska1, Peter K Yang2, Joshua J Neumiller3
1Division of Endocrinology and Metabolism, Department of Nutrition, Gillings School of Global Public Health and UNC Center for Aging and Health, University of North Carolina, Chapel Hill, NC, USA.
The Lancet. Diabetes & Endocrinology
|July 30, 2026
Summary
Global survival for type 1 diabetes has improved, but inequities persist. Aging with type 1 diabetes requires examining health systems and social factors beyond glucose control.
Area of Science:
- Endocrinology and Metabolism
- Global Health
- Gerontology
Background:
- Life expectancy for type 1 diabetes has significantly increased in high-income nations.
- Global disparities in survival rates for type 1 diabetes persist, particularly in low- and middle-income countries.
- An increasing number of individuals with type 1 diabetes are living into older adulthood, necessitating a broader health perspective.
Purpose of the Study:
- To review the multifaceted challenges of aging with type 1 diabetes.
- To integrate psychosocial, environmental, and societal factors impacting longevity.
- To identify critical research gaps for future studies on type 1 diabetes across the life course.
Main Methods:
- This is a review article, synthesizing existing literature.
- Focuses on disease burden, health system responses, self-care, and caregiver support.
- Considers the influence of global context and determinants of health.
Main Results:
- Significant global inequities in survival for type 1 diabetes patients exist.
- Aging populations with type 1 diabetes require comprehensive health system and societal considerations.
- Psychosocial and environmental factors are crucial in managing long-term health.
Conclusions:
- Addressing global inequities in type 1 diabetes care is paramount.
- Future research must adopt a life-course perspective, incorporating social determinants of health.
- Holistic approaches are needed to support aging individuals with type 1 diabetes.
Related Concept Videos
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...